SOCM
SR One Capital Management Portfolio holdings
AUM
$461M
This Quarter Return
+58.37%
1 Year Return
+23.25%
3 Year Return
+188.96%
5 Year Return
–
10 Year Return
–
AUM
$238M
AUM Growth
+$238M
(+22%)
Cap. Flow
-$48.4M
Cap. Flow
% of AUM
-20.33%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Arcellx
ACLX
|
$44.4M |
| 2 |
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
$4.03M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Arcellx
ACLX
$3.85B
| $175M | 73.33% |
3,146,630
-800,000
| -20% | -$44.4M |
|
2
ARS Pharmaceuticals
SPRY
$1.15B
| $22M | 9.23% |
4,012,903
| – | – |
|
3
Design Therapeutics
DSGN
$315M
| $17.3M | 7.26% |
6,526,476
| – | – |
|
4
Mineralys Therapeutics
MLYS
$1.03B
| $15.4M | 6.48% |
1,794,600
| – | – |
|
5
Nkarta
NKTX
$151M
| $8.8M | 3.7% |
1,333,333
| – | – |
|
|
EFTR
6
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| – | – |
-6,822,114
| Closed | -$4.03M |
|